Ubiquitin-proteasome system and hereditary cardiomyopathies
about
Ongoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?Animal and in silico models for the study of sarcomeric cardiomyopathiesResearch priorities in sarcomeric cardiomyopathiesMybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceProtein quality control and metabolism: bidirectional control in the heartMutations in proteasome-related genes are associated with thyroid hemiagenesisTherapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome SequencingTRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.Cardiac fibrosis in mouse expressing DsRed tetramers involves chronic autophagy and proteasome degradation insufficiency.Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy.The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy-Progress and Novel Therapeutic Opportunities.Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential.Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathyGenetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload.Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood-Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain.Mutant Muscle LIM Protein C58G causes cardiomyopathy through protein depletionEmergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
P2860
Q26800197-8977BD09-B11D-4A84-AA9F-9598989C3320Q26865437-81C40627-4AC0-4F91-A0E1-AB70D90D766EQ27694507-B88747B5-5587-4C39-A444-DCB5985F2367Q28253008-68C28C7A-452E-4D4D-8449-1E5EFE1602E0Q28256472-A8D5F563-2F18-4497-9898-BE1F45D09C48Q33575777-83CD9DB3-9557-44D3-B3CF-2BC31F428644Q35895152-BE2F574F-282E-419B-BB97-5990AE5C5296Q36287303-30A3B8F1-4A98-45E3-8E57-1D599DE6ADDDQ36361387-398C63E8-F7B9-49DC-A88C-6CE7313DA9BFQ37688051-745FC8E4-6F67-4941-80F5-4A7C106F5E68Q38851025-3BF149E2-FC50-4B76-BB45-61757CD9F0ACQ38978665-1D68476C-9B6A-44CE-A3E9-EFBC715D2C3FQ39411678-BD3C97B3-A2D1-4CF5-9CE2-3D25A959E269Q40765741-EF301546-D38A-43A6-A42A-78C4B9C560C6Q42428235-CA55554F-6B02-481E-B5C4-F0186EB4F149Q42504304-41E286F7-DA28-4EFA-8ABE-DD5C61704CC5Q48111333-0C840D8E-62C5-426B-BD16-B0E3DCA2EDECQ57202117-500E84C9-0A6B-4429-B99B-9928FB6084D6Q58728912-B9B34525-E2F0-4AEF-B263-4E8B383F243B
P2860
Ubiquitin-proteasome system and hereditary cardiomyopathies
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Ubiquitin-proteasome system and hereditary cardiomyopathies
@ast
Ubiquitin-proteasome system and hereditary cardiomyopathies
@en
Ubiquitin-proteasome system and hereditary cardiomyopathies
@nl
type
label
Ubiquitin-proteasome system and hereditary cardiomyopathies
@ast
Ubiquitin-proteasome system and hereditary cardiomyopathies
@en
Ubiquitin-proteasome system and hereditary cardiomyopathies
@nl
prefLabel
Ubiquitin-proteasome system and hereditary cardiomyopathies
@ast
Ubiquitin-proteasome system and hereditary cardiomyopathies
@en
Ubiquitin-proteasome system and hereditary cardiomyopathies
@nl
P1476
Ubiquitin-proteasome system and hereditary cardiomyopathies
@en
P2093
Norbert Frey
P356
10.1016/J.YJMCC.2013.12.016
P407
P577
2014-06-01T00:00:00Z